Log In
Print
BCIQ
Print
Print this Print this
 

TT-601

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSmall molecule that binds an undisclosed nuclear receptor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat osteoarthitis (OA) pain
Regulatory Designation

Partner

Transition Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today